Ross JS - Search Results

1

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.

Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross JS, Cordon-Cardo C. Osman I, et al. Among authors: ross js. Clin Cancer Res. 2001 Sep;7(9):2643-7. Clin Cancer Res. 2001. PMID: 11555574

2

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis.

Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifkin MD, Fisher HA. Ross JS, et al. Cancer. 1993 Nov 15;72(10):3020-8. doi: 10.1002/1097-0142(19931115)72:10<3020::aid-cncr2820721026>3.0.co;2-#. Cancer. 1993. PMID: 8106140

3

Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.

Kallakury BV, Yang F, Figge J, Smith KE, Kausik SJ, Tacy NJ, Fisher HA, Kaufman R, Figge H, Ross JS. Kallakury BV, et al. Among authors: ross js. Cancer. 1996 Oct 1;78(7):1461-9. doi: 10.1002/(sici)1097-0142(19961001)78:7<1461::aid-cncr13>3.0.co;2-y. Cancer. 1996. PMID: 8839552

4

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.

Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, Fisher HA, Rifkin MD, Muraca PJ. Ross JS, et al. Cancer. 1997 Jun 1;79(11):2162-70. doi: 10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u. Cancer. 1997. PMID: 9179063

5

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.

Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Ross JS. Kallakury BV, et al. Among authors: ross js. Cancer. 1997 Aug 15;80(4):753-63. doi: 10.1002/(sici)1097-0142(19970815)80:4<753::aid-cncr15>3.0.co;2-s. Cancer. 1997. PMID: 9264360

6

Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.

Riben MW, Malfetano JH, Nazeer T, Muraca PJ, Ambros RA, Ross JS. Riben MW, et al. Among authors: ross js. Mod Pathol. 1997 Aug;10(8):823-31. Mod Pathol. 1997. PMID: 9267826

7

Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas.

Scalzo DA, Kallakury BV, Gaddipati RV, Sheehan CE, Keys HM, Savage D, Ross JS. Scalzo DA, et al. Among authors: ross js. Am J Clin Pathol. 1998 Feb;109(2):163-8. doi: 10.1093/ajcp/109.2.163. Am J Clin Pathol. 1998. PMID: 9583887

8

Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.

Tran TA, Kallakury BV, Ambros RA, Ross JS. Tran TA, et al. Among authors: ross js. Cancer. 1998 Jul 15;83(2):276-82. Cancer. 1998. PMID: 9669810

9

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

Ross JS, Fletcher JA. Ross JS, et al. Stem Cells. 1998;16(6):413-28. doi: 10.1002/stem.160413. Stem Cells. 1998. PMID: 9831867 Review.

10

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.

Kallakury BV, Sheehan CE, Rhee SJ, Fisher HA, Kaufman RP Jr, Rifkin MD, Ross JS. Kallakury BV, et al. Among authors: ross js. Cancer. 1999 Apr 1;85(7):1569-76. doi: 10.1002/(sici)1097-0142(19990401)85:7<1569::aid-cncr19>3.0.co;2-m. Cancer. 1999. PMID: 10193948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,800 results

Search Page

Filters